Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 71Pancreatic Neoplasms 69Colorectal Neoplasms 26Liver Neoplasms 20Neoplasm Metastasis 9Lung Neoplasms 8Melanoma 7Cholangiocarcinoma 6Sarcoma 5Neoplasms 5Colonic Neoplasms 5Breast Neoplasms 5Stomach Neoplasms 4Gastrointestinal Neoplasms 4Esophageal Neoplasms 4Carcinoma, Renal Cell 4Brain Neoplasms 4Klatskin Tumor 3Urinary Bladder Neoplasms 2Unresectable Locally Recurrent Rectal Cancer 2Thyroid Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Locally Advanced Pancreatic Cancer 2Carcinoma, Non-Small-Cell Lung 2Bile Duct Neoplasms 2Adrenal Gland Neoplasms 2Uterine Cervical Neoplasms 1Testicular Neoplasms 1Spinal Cord Compression 1

Interventions

Sorafenib 5lenvatinib 3sintilimab 2pembrolizumab 2halofantrine 2camrelizumab 2atezolizumab 2Immunotherapy 2Blood Specimen Collection 2Bevacizumab 2Antibodies 2trifluridine tipiracil drug combination 1trametinib 1toripalimab 1titanium silicide 1tislelizumab 1linifanib 1genexol-PM 1gadolinium ethoxybenzyl DTPA 1fluorocholine 1fisogatinib 1ficlatuzumab 1durvalumab 1bavituximab 1avelumab 1User-Centered Design 1Sunitinib 1Sufentanil 1Standard of Care 1Shadowing Technique, Histology 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Diseases × Radiosurgery × Gastrointestinal × Clear all
NCT02989870 2020-06-05

Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡